Form 4: Welltower Director Andrew Gundlach Boosts Stake with Over $3 Million Share Purchase

Welltower Inc. Director Andrew Gundlach acquired 20,000 shares of common stock for over $3 million through two trusts, signaling increased insider confidence in the company.

Summary

• Andrew Gundlach, a Director of Welltower Inc., acquired a total of 20,000 shares of common stock.
• The shares were purchased on June 30, 2025, at a weighted average price of $151.46 per share.
• The total value of the acquisition is approximately $3,029,200.
• The purchases were made indirectly through two separate trusts: 10,000 shares via the Ellen-Maria Gorrissen Trust I and 10,000 shares via the Ellen-Maria Gorrissen Trust II.
• Following these transactions, the Ellen-Maria Gorrissen Trust I beneficially owns 10,000 shares, and the Ellen-Maria Gorrissen Trust II beneficially owns 20,000 shares.
• Andrew Gundlach is the Chairman and Chief Executive Officer of Bleichroeder LP, which serves as the registered investment adviser to both trusts.
• Gundlach disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest.

Sentiment

Score: 8

Explanation: The significant insider purchase by a director indicates strong confidence in the company's future, which is a highly positive signal for investors.

Positives

• Significant insider buying by a Director, indicating strong confidence in the company's future prospects.
• The purchase of 20,000 shares represents a substantial investment of approximately $3.03 million by a key insider.
• The transaction was executed at a weighted average price of $151.46, suggesting management believes the stock is a good value at this level.

Risks

• No specific operational or financial risks for Welltower Inc. are disclosed in this Form 4 filing, which primarily reports a stock transaction.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding Welltower Inc.'s future outlook.

Management Comments

• The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
• The reporting person, on his own behalf and on behalf of Bleichroeder LP, disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that either the reporting person or Bleichroeder LP is the beneficial owner of the securities for purposes of Section 16 or for any other purposes.

Industry Context

Insider buying, particularly by a director, in a Real Estate Investment Trust (REIT) like Welltower, which specializes in healthcare properties, can signal management's positive view on the sector's stability and growth prospects, especially given demographic trends favoring healthcare real estate.

Comparison to Industry Standards

• Insider purchases of this magnitude (over $3 million) are significant and often viewed positively by the market, as they align management's interests with those of shareholders.
• Compared to typical insider transactions, a director acquiring 20,000 shares is a substantial vote of confidence, especially for a large-cap REIT like Welltower, which is a leader in the healthcare real estate sector alongside peers such as Ventas (VTR) and Healthpeak Properties (PEAK).
• The weighted average purchase price of $151.46 falls within a narrow range ($151.23 to $151.77), indicating a consistent valuation perspective during the acquisition period.

Related Party Transactions

• The transaction involves indirect beneficial ownership through two trusts (Ellen-Maria Gorrissen Trust I and Trust II) for which Andrew Gundlach is the Chairman and CEO of the registered investment adviser (Bleichroeder LP) and a beneficiary of Trust I, indicating a related party transaction.

Stakeholder Impact

• Shareholders: The insider purchase may instill greater confidence among existing and potential shareholders, potentially leading to increased demand for the stock.
• Management: The transaction aligns the director's financial interests more closely with the company's performance, reinforcing commitment.

Next Steps

• The reporting person undertakes to provide full information regarding the number of shares purchased at each separate price within the reported range upon request from the issuer, security holders, or the SEC staff.

Key Dates

Recommendation

Keywords

Welltower, WELL, Andrew Gundlach, Insider Buying, Form 4, Director Stock Purchase, Real Estate Investment Trust, Healthcare REIT, Stock Acquisition, Beneficial Ownership